ea0077p36 | Endocrine Cancer and Late Effects | SFEBES2021
Walsh Emma
, Ravindiran Abiramie
, Paramore Jane
, Bates Suzanna
, Ibbotson Vicky
, Dunkley Kay
, Munir Alia
Introduction: The global impact of COVID-19 has been unprecedented. Specific recommendations for the management of neuroendocrine disorders in the pandemic were rapidly released by Endocrine experts. To comply with COVID rules, NET patients, due to attend the endocrine unit in March 2020 for Somatostatin analogue therapy, were rapidly identified. 25 vulnerable patients had urgent domiciliary administration arranged. Other patients were taught to self-inject. Postal surveys wer...